Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GNMSF) Exchange Rate Effect (2023 - 2025)

Historic Exchange Rate Effect for Genmab A (GNMSF) over the last 3 years, with Q4 2025 value amounting to -$4.0 million.

  • Genmab A's Exchange Rate Effect fell 11379.31% to -$4.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.0 million, marking a year-over-year decrease of 9523.81%. This contributed to the annual value of $3.0 million for FY2025, which is 9523.81% down from last year.
  • Latest data reveals that Genmab A reported Exchange Rate Effect of -$4.0 million as of Q4 2025, which was down 11379.31% from $4.0 million recorded in Q3 2025.
  • In the past 5 years, Genmab A's Exchange Rate Effect registered a high of $49.0 million during Q3 2024, and its lowest value of -$14.0 million during Q2 2024.
  • For the 3-year period, Genmab A's Exchange Rate Effect averaged around $6.0 million, with its median value being -$1.0 million (2024).
  • The largest annual percentage gain for Genmab A's Exchange Rate Effect in the last 5 years was 90000.0% (2025), contrasted with its biggest fall of 11379.31% (2025).
  • Quarter analysis of 3 years shows Genmab A's Exchange Rate Effect stood at -$12.0 million in 2023, then soared by 341.67% to $29.0 million in 2024, then tumbled by 113.79% to -$4.0 million in 2025.
  • Its Exchange Rate Effect was -$4.0 million in Q4 2025, compared to $4.0 million in Q3 2025 and -$5.0 million in Q2 2025.